Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma

13 Jan 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Relapsed Advanced Lymphomas · Phase 1 · Enrollment 40 · Sponsor: Aurigene Discovery Technologies Limited

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 13 Jan 2026. The item focuses on Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma. Open the detail page to review the full original feed content.